Two patients with multiple organ systems failure developed seizures after receiving imipenem/cilastatin (I/C) despite dose adjustment for poor renal function. Neither patient had a past history of seizures, nor had experienced seizures after receiving high doses of other beta-lactam antibiotics. Simple dose adjustment of I/C based on low creatinine clearances may not be adequate to prevent seizures.
Get full access to this article
View all access options for this article.
References
1.
JobMLDretlerRH. Seizure activity with imipenem therapy: Incidence and risk factors. DICP Ann Pharmacother1990; 24: 467–9.
2.
NeuHC. Carbapenems: Special properties contributing to their activity. Am J Med1985; 78 (suppl 6A):33–40.
3.
GibsonTPDemetriadesJLBlandJA. Imipenem/cilastatin: Pharmacokinetic profile in renal insufficiency. Am J Med1985; 78 (suppl 6A):54–61.
4.
CalandraGBBrownKRGradLCAhonkhaiVIWangCAzizMA. Review of adverse experiences and tolerability in the first 2516 patients treated with imipenem/cilastatin. Am J Med1985; 78 (suppl 6A):73–8.
5.
CalandraGBWangCAzizMBrownKR. The safety profile of imipenem/cilastatin: Worldwide clinical experience based on 3470 patients. J Antimicrob Chemother1986; 18 (suppl E): 193–202.
6.
Package insert. Primaxin (imipenem-cilastatin sodium). West Point, PA: Merck Sharp and Dohme, November 1985.
7.
BrothertonTJKelberRL. Seizure-like activity associated with imipenem. Clin Pharm1984; 3: 536–40.
8.
EngRHMunsifANYangoBGSmithSMEnmelH. Seizure propensity with imipenem. Arch Intern Med1989; 149: 1881–3.
9.
TseCSTVeraFHDesaiDV. Seizure-like activity associated with imipenem-cilastatin (letter). Drug Intell Clin Pharm1987; 21: 659–60.
10.
KameiCSunamiATusakaK. Epileptogenic activity of cephalosporins in rats and their structure-activity relationship. Epilepsia1983; 24: 431–9.
11.
CalandraGBLydickECarriganJWeissLGuessH. Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem/cilastatin. Am J Med1988; 84: 911–8.
ModaiJVittecoqDCecazesJMMeulemansA. Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis. J Antimicrob Chemother1985; 16: 751–5.
14.
FreemanRBSheffMFMatterJFSchreinerGE. The blood-cerebrospinal fluid barrier in uremia. Ann Intern Med1962; 56: 233–40.
15.
BermanSTSugiharaJGNakamuraJM. Multiple-dose study of imipenem/cilastatin in patients with end-stage renal disease undergoing long term hemodialysis. Am J Med1985; 78 (suppl 6A): 113–6.
16.
YuQHKitazumiKKameiCTasaraK. Epileptogenic activity induced by intravenous injection of certain cephalosporins in rats. J Pharmacol Dynam1984; 7: 586–92.